IN2014DN07984A - - Google Patents
Info
- Publication number
- IN2014DN07984A IN2014DN07984A IN7984DEN2014A IN2014DN07984A IN 2014DN07984 A IN2014DN07984 A IN 2014DN07984A IN 7984DEN2014 A IN7984DEN2014 A IN 7984DEN2014A IN 2014DN07984 A IN2014DN07984 A IN 2014DN07984A
- Authority
- IN
- India
- Prior art keywords
- chloroacetone
- dimethylbenzene
- bromo
- preparation
- discloses
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261665510P | 2012-06-28 | 2012-06-28 | |
EP12174102 | 2012-06-28 | ||
EP12188104 | 2012-10-11 | ||
PCT/EP2012/070875 WO2012172121A1 (en) | 2012-06-28 | 2012-10-22 | Method for the preparation of medetomidine with chloroacetone |
EP12192625 | 2012-11-14 | ||
PCT/EP2012/072798 WO2013011157A1 (en) | 2012-06-28 | 2012-11-15 | Method for preparation of medetomidine with chloroacetone |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN07984A true IN2014DN07984A (de) | 2015-05-01 |
Family
ID=47557694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN7984DEN2014 IN2014DN07984A (de) | 2012-06-28 | 2012-11-15 |
Country Status (21)
Country | Link |
---|---|
US (2) | US9156793B2 (de) |
EP (1) | EP2867211B1 (de) |
JP (1) | JP5777841B2 (de) |
KR (1) | KR101560116B1 (de) |
CN (2) | CN104245678B (de) |
AU (1) | AU2012285677B2 (de) |
CA (1) | CA2866437C (de) |
CL (2) | CL2014002907A1 (de) |
CY (1) | CY1117492T1 (de) |
DK (1) | DK2867211T3 (de) |
EA (1) | EA027921B1 (de) |
ES (1) | ES2565066T3 (de) |
HK (2) | HK1201530A1 (de) |
HR (1) | HRP20160216T1 (de) |
HU (1) | HUE027382T2 (de) |
IN (1) | IN2014DN07984A (de) |
MY (1) | MY165218A (de) |
PL (1) | PL2867211T3 (de) |
SG (1) | SG11201405609WA (de) |
TW (2) | TWI543970B (de) |
WO (1) | WO2013011157A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201405606RA (en) | 2012-05-08 | 2014-11-27 | Lonza Ag | Method for preparation of medetomidine |
KR101537204B1 (ko) | 2012-05-08 | 2015-07-22 | 론자 아게 (론자 엘티디.) | 2-(2,3-디메틸페닐)-1-프로파날의 제조 방법 |
PL2867195T3 (pl) | 2012-06-28 | 2016-06-30 | Lonza Ag | Sposób wytwarzania 2-(2,3-dimetylofenylo)-1-propanalu przy pomocy chloroacetonu |
CN104245678B (zh) * | 2012-06-28 | 2016-02-24 | 隆萨有限公司 | 用氯丙酮制备美托咪定的方法 |
WO2017138224A1 (ja) * | 2016-02-12 | 2017-08-17 | ソニー株式会社 | 装置及び方法 |
CN106518812A (zh) * | 2016-10-25 | 2017-03-22 | 湖南大学 | 一种美托咪定及其中间体的制备方法 |
CN113044857B (zh) * | 2020-12-30 | 2023-05-23 | 重庆柒兴克米科技有限公司 | 高收率制取高纯氰化钠或氰化钾的生产工艺 |
CN114671811A (zh) * | 2022-04-14 | 2022-06-28 | 南京正科医药股份有限公司 | 一种右美托咪定拆分副产物的外消旋化回收方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE23400E (en) | 1951-08-14 | Electkic low and high-voltage fuses | ||
BE790604A (fr) | 1971-10-28 | 1973-04-26 | Sandoz Sa | Nouveaux aminoalcanols, leur preparation et leur application comme medicaments |
JPS51100042A (en) | 1975-02-26 | 1976-09-03 | Kanebo Ltd | 22 * 44 isobuchirufueniru * puropionsanno seizoho |
JPS51100041A (en) | 1975-02-26 | 1976-09-03 | Kanebo Ltd | 22 * 44 isobuchirufueniru * puropionsanno seizoho |
GB2092569B (en) | 1981-02-05 | 1984-09-19 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
GB2101114B (en) | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
ATE78722T1 (de) | 1984-02-24 | 1992-08-15 | Sagami Chem Res | Methode zum isomerisieren eines glycidats. |
JPS62103037A (ja) * | 1985-10-29 | 1987-05-13 | Hamari Yakuhin Kogyo Kk | 2−(4−イソブチルフエニル)−プロピオンアルデヒドの製造法 |
DE19714042A1 (de) | 1997-04-05 | 1998-10-08 | Henkel Kgaa | Verfahren zur Herstellung aromatischer Aldehyde |
SE513474C2 (sv) | 1999-01-25 | 2000-09-18 | Hans Elwing Instutionen Foer C | Metod för att förhindra kräftdjurs, särskilt havstulpaners, etablering på fasta ytor med hjälp av en substans som stör nervsignaler, varvid substansen är medetomidin, dvs (+)-4-/1- (2,3-dimetylfenyl)-etyl/-IH-imidazol |
EP1918282A1 (de) * | 2006-11-06 | 2008-05-07 | "Joint Stock Company Grindeks" | Verfahren zur Herstellung von Medetomidine und ihre Salzen |
GB2453982B (en) * | 2007-10-24 | 2009-09-16 | Norbrook Lab Ltd | Chemical process for the preparation of Medetomidine |
US7902247B2 (en) | 2008-01-09 | 2011-03-08 | Allergan, Inc. | Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors |
CN101921234B (zh) * | 2009-06-12 | 2012-05-30 | 中国中化股份有限公司 | 一种制备美托咪啶的方法 |
WO2011070069A1 (en) | 2009-12-09 | 2011-06-16 | I-Tech Ab | Process for preparation of medetomidine |
KR101537204B1 (ko) | 2012-05-08 | 2015-07-22 | 론자 아게 (론자 엘티디.) | 2-(2,3-디메틸페닐)-1-프로파날의 제조 방법 |
SG11201405606RA (en) * | 2012-05-08 | 2014-11-27 | Lonza Ag | Method for preparation of medetomidine |
WO2012172119A2 (en) * | 2012-05-08 | 2012-12-20 | Lonza Ltd | Method for the preparation of medetomidine |
WO2012172120A2 (en) | 2012-05-08 | 2012-12-20 | Lonza Ltd | 2-(2,3-dimethylphenyl)-1-propanal and its use as perfume |
CN104245678B (zh) * | 2012-06-28 | 2016-02-24 | 隆萨有限公司 | 用氯丙酮制备美托咪定的方法 |
WO2012172121A1 (en) * | 2012-06-28 | 2012-12-20 | Lonza Ltd | Method for the preparation of medetomidine with chloroacetone |
PL2867195T3 (pl) | 2012-06-28 | 2016-06-30 | Lonza Ag | Sposób wytwarzania 2-(2,3-dimetylofenylo)-1-propanalu przy pomocy chloroacetonu |
WO2012172122A2 (en) * | 2012-06-28 | 2012-12-20 | Lonza Ltd | Method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal |
-
2012
- 2012-11-15 CN CN201280072210.0A patent/CN104245678B/zh not_active Expired - Fee Related
- 2012-11-15 ES ES12787007.9T patent/ES2565066T3/es active Active
- 2012-11-15 JP JP2015510662A patent/JP5777841B2/ja not_active Expired - Fee Related
- 2012-11-15 WO PCT/EP2012/072798 patent/WO2013011157A1/en active Application Filing
- 2012-11-15 EP EP12787007.9A patent/EP2867211B1/de not_active Not-in-force
- 2012-11-15 CA CA2866437A patent/CA2866437C/en not_active Expired - Fee Related
- 2012-11-15 SG SG11201405609WA patent/SG11201405609WA/en unknown
- 2012-11-15 MY MYPI2014002579A patent/MY165218A/en unknown
- 2012-11-15 US US14/385,797 patent/US9156793B2/en not_active Expired - Fee Related
- 2012-11-15 HU HUE12787007A patent/HUE027382T2/en unknown
- 2012-11-15 CN CN201510621358.0A patent/CN105218453B/zh not_active Expired - Fee Related
- 2012-11-15 KR KR1020147029607A patent/KR101560116B1/ko active IP Right Grant
- 2012-11-15 DK DK12787007.9T patent/DK2867211T3/en active
- 2012-11-15 AU AU2012285677A patent/AU2012285677B2/en not_active Ceased
- 2012-11-15 EA EA201400939A patent/EA027921B1/ru not_active IP Right Cessation
- 2012-11-15 PL PL12787007T patent/PL2867211T3/pl unknown
- 2012-11-15 IN IN7984DEN2014 patent/IN2014DN07984A/en unknown
-
2013
- 2013-06-26 TW TW102122683A patent/TWI543970B/zh not_active IP Right Cessation
- 2013-06-26 TW TW105114874A patent/TWI560182B/zh not_active IP Right Cessation
-
2014
- 2014-10-27 CL CL2014002907A patent/CL2014002907A1/es unknown
-
2015
- 2015-03-03 HK HK15102120.2A patent/HK1201530A1/zh not_active IP Right Cessation
- 2015-07-30 US US14/813,681 patent/US9434694B2/en not_active Expired - Fee Related
-
2016
- 2016-02-22 HK HK16101923.2A patent/HK1213893A1/zh not_active IP Right Cessation
- 2016-03-01 HR HRP20160216T patent/HRP20160216T1/hr unknown
- 2016-03-16 CY CY20161100222T patent/CY1117492T1/el unknown
- 2016-06-29 CL CL2016001664A patent/CL2016001664A1/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014DN08121A (de) | ||
IL249367A0 (en) | Altered [4,2,1]triazole compounds | |
EP2936375A4 (de) | Zeitgerechte, e-mail-eingebettete url-reputationsbestimmung | |
IN2014DN07984A (de) | ||
MX2014002053A (es) | Anticuerpos anti -mcsp y metodos de uso. | |
IN2014DN07983A (de) | ||
JO3755B1 (ar) | تركيبات تستوستيرون | |
WO2012172122A3 (en) | Method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal | |
IN2014CN04050A (de) | ||
WO2014145897A3 (en) | Immunotherapy system and method thereof | |
WO2012172119A3 (en) | Method for the preparation of medetomidine | |
IN2014DN09798A (de) | ||
WO2014091167A3 (fr) | Composes cyclopropylboroniques, leur procede de preparation et leur utilisation | |
EP3184172B8 (de) | Hydrosilylierungseisenkatalysator | |
IN2014CN00312A (de) | ||
EA201400937A1 (ru) | Способ получения 2-(2,3-диметилфенил)-1-пропаналя | |
MY165088A (en) | Pharmaceutical compositions comprising alisporivir | |
EP3281180A4 (de) | Erzeugung von optimierten geometrien | |
IN2012DN01971A (de) | ||
GB201012359D0 (en) | Invention 6.5.10 | |
IL239340A0 (en) | Sage fragrance | |
WO2014093305A3 (en) | Micrornas and uses thereof | |
GB201015621D0 (en) | Invention 30.08.10 | |
UA111528C2 (uk) | Спосіб одержання 2-(2,3-диметилфеніл)-1-пропаналю з використанням хлорацетону | |
MX2016016577A (es) | Aleacion de fundicion de aluminio. |